Delcath Systems

+$0.06 (+1.33%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCTH and other ETFs, options, and stocks.

About DCTH

Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan Hydrochloride for Injection, which is a proprietary product used with the Delcath Hepatic Delivery System.

CEO
Gerard J. Michel
Employees
55
Headquarters
New York, New York
Founded
1988

DCTH Key Statistics

Market cap
36.05M
Price-Earnings ratio
—
Dividend yield
—
Average volume
24.50K
High today
$4.61
Low today
$4.41
Open price
$4.61
Volume
17.52K
52 Week high
$13.50
52 Week low
$4.30

DCTH Earnings

-$1.63
-$1.09
-$0.54
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure